Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluoride + sodium fluoride refers to a specific combination therapy evaluated for the prevention and remineralization of dental white spot lesions and caries, particularly in orthodontic patients. This regimen involves the application of MI Varnish, a 5% sodium fluoride treatment, in conjunction with MI Paste Plus, a topical cream containing casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and fluoride. The mechanism of action involves the delivery of fluoride, calcium, and phosphate ions to the tooth surface, where they promote the formation of fluorapatite and stabilize amorphous calcium phosphate, thereby enhancing the remineralization of hydroxyapatite and increasing the enamel's resistance to acid-induced demineralization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluoride + sodium fluoride.